Your session is about to expire
← Back to Search
Dutasteride + Dietary Interventions for Prostate Cancer
Study Summary
This trial will test whether marine omega-3 fatty acids and 5-alpha-reductase inhibitors can help low-risk prostate cancer patients by slowing the progression of the disease.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My condition is being monitored rather than actively treated.I am currently taking NSAID medication.My prostate cancer is considered low risk.
- Group 1: Dietary intervention first
- Group 2: Drug intervention first
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment recruiting participants who are older than thirty years of age?
"This trial is open to individuals aged 35 and over, up to 75 years of age."
Is there room to accommodate new participants in this research endeavor?
"This clinical trial is not seeking further candidates. It was first announced in November 2010 and last amended on March 14th 2022. For those looking for similar studies, 1252 trials related to prostate cancer are currently accepting new patients; 6 of which employ Dutasteride as an intervention."
What is the upper limit of participants in this medical research?
"This medical trial is no longer recruiting. It was initially posted on November 1st 2010 and last revised March 14th 2022. As of now, there are 1252 active clinical trials with a focus on prostate cancer and 6 specifically looking at the efficacy of dutasteride as an intervention that are enrolling patients."
What criteria must be met for a patient to qualify for this clinical research?
"To enroll in this study, patients aged 35-75 with prostate cancer must meet the following criteria: low risk prostatic neoplasms, candidate for active surveillance, and signing of an informed consent. A total of 120 participants are needed."
Share this study with friends
Copy Link
Messenger